GRCE

Grace Therapeutics
GRCE

13 hedge funds and large institutions have $2.92M invested in Grace Therapeutics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$114K
2
+$18.3K
3
+$11.5K
4
Morgan Stanley
Morgan Stanley
New York
+$7.12K
5
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$4.57K

Top Sellers

1
-$63K
2
-$25K
3
-$16.7K
4
UBS Group
UBS Group
Switzerland
-$12.6K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$4K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.03M
2
$380K
3
$289K
4
$68K
5
$52K
6
$45.6K
7
$23K
8
$15K
9
$7K
10
$5K
11
$1K
12
$1K
13
$34
14
–
15
–